SEC Form 4 · accession 0001209191-16-129781
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald K. Brandom
Officer — SVP, Product Development
Period of report
Jun 23, 2016
Accepted (ET)
Jun 27, 2016 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 23, 2016 | S | 463 | $7.795 | D | 74,587 | D | |
| Common StockF1,F2 | Jun 23, 2016 | S | 463 | $7.795 | D | 74,124 | D | |
| Common StockF3,F2 | Jun 24, 2016 | S | 5 | $7.438 | D | 74,119 | D | |
| Common StockF4,F2 | Jun 24, 2016 | S | 1,000 | $7.3645 | D | 73,119 | D | |
| Common StockF5,F2 | Jun 24, 2016 | S | 2,074 | $7.29 | D | 71,045 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the sale of 4,630 of the Company's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange ("ASX").
- F2The sale was executed in the form of CDIs trading on the ASX and, as such, the sale price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
- F3Represents the sale of 54 of the Company's CDIs trading on the ASX.
- F4Represents the sale of 10,000 of the Company's CDIs trading on the ASX.
- F5Represents the sale of 20,740 of the Company's CDIs trading on the ASX.